Additionally, several studies revealed the suppressive function of NRF2 in tumorigenesis, namely, BC, gastric cancer, leukemia, prostate cancer, colorectal cancer, melanomas and so forth (8–13). This evidence concerns the gene NFE2L2 and breast cancer.